Clinical trial Recruiting at 8 sites Interventional Ages 19 and up

LEXURE digital language therapy for post-stroke aphasia

Official title: A Prospective, Multicenter, Randomized, Evaluator-Blinded, Confirmatory Study to Evaluate the Efficacy and Safety of LEXURE for Improving Language Function in Patients With Post-Stroke Aphasia

Run by Nunaps Inc · NCT07570264 · Data updated 2026-11-12

This trial will test whether using the LEXURE app helps adults with post-stroke aphasia improve language more than workbook-based practice.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment116 (estimated)
SponsorNunaps Inc
Industry-sponsored
Locations12 sites (Ansan, Gyeonggi-do and 11 other locations)
StatusRecruiting
StartedApril 16, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07570264 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (19+) who are native Korean speakers with post-stroke aphasia at least 3 months after stroke and an AQ score of 26–90 who can use the app or complete workbook tasks are ideal candidates.

Probably not a fit

People whose language problems are due to non-stroke causes (e.g., traumatic brain injury, tumor, neurodegenerative disease), developmental language disorders, or who are already receiving active speech-language therapy or a related clinical trial are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, randomized, evaluator-blinded confirmatory trial comparing a digital therapeutic (LEXURE) to a workbook-based active comparator in people with post-stroke aphasia. Eligible adults (≥19 years) at least 3 months after ischemic or hemorrhagic stroke with an Aphasia Quotient of 26–90 will be randomized 1:1. The LEXURE group will do ~30-minute digital training sessions five times weekly for 10 weeks while the control group will follow matched workbook tasks on the same schedule. Primary outcomes use the K-WAB/PK-WAB-R scored by independent, blinded assessors to measure language change and safety over the intervention period.

Why it matters

Potential benefit: If successful, LEXURE could improve language recovery and increase access to structured speech practice by providing scalable digital therapy.

How similar studies have gone: Smaller studies of digital and structured therapy approaches for post-stroke aphasia have shown promising results, but large confirmatory trials comparing digital tools to active workbook-based interventions remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosed with hemorrhagic or ischemic stroke
2. At least 3 months have elapsed since stroke onset
3. History of aphasia resulting from stroke
4. Aphasia Quotient (AQ) score between 26 and 90 (inclusive) on the Korean version of the Western Aphasia Battery (K-WAB) or the Paradise Korean version of the Western Aphasia Battery-Revised (PK-WAB-R)
5. Adults aged 19 years or older
6. Native Korean speakers
7. Able to use the investigational device or perform workbook-based training without difficulty
8. Willing to participate voluntarily and provide written informed consent

Exclusion Criteria:

1. Diagnosed with language impairment due to causes other than stroke (e.g., traumatic brain injury, brain tumor, or neurodegenerative disease)
2. History of language impairment due to developmental disorders
3. Currently receiving speech-language therapy or participating in another clinical trial related to language function
4. Currently receiving medication for severe psychiatric disorders (e.g., bipolar disorder, major depressive disorder, schizophrenia, alcohol dependence, or substance abuse)
5. Illiterate individuals
6. Individuals deemed unsuitable for participation in this study by the investigator
7. Severe cognitive impairment that would interfere with understanding or performing the study interventions

Where it's running

  • Inje University Busan Paik Hospita
    Busan, South Korea
    Recruiting
  • Hallym University Chuncheon Sacred Heart Hospital
    Chuncheon, South Korea
    Recruiting
  • Keimyung University Dongsan Hospital
    Daegu, South Korea
    Recruiting
  • Chonnam National University Hospital
    Gwangju, South Korea
    Recruiting
  • Inje University Ilsan Paik Hospital
    Ilsan, South Korea
    Recruiting
  • Asan Medical Center
    Seoul, South Korea
    Recruiting
Show 6 more locations
  • Konkuk University Medical Center
    Seoul, South Korea
    Recruiting
  • Ulsan University Hospital
    Ulsan, South Korea
    Recruiting
  • Korea University Ansan Hospital
    Ansan, Gyeonggi-do, South Korea
    Not yet recruiting
  • Kyungpook National University Hospital
    Daegu, South Korea
    Not yet recruiting
  • Yeungnam University Medical Center
    Daegu, South Korea
    Not yet recruiting
  • Jeonbuk National University Hospital
    Jeonju, South Korea
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.